ADAR1 Capital Management »

Amphastar Pharmaceuticals shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Amphastar Pharmaceuticals (AMPH) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Amphastar Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amphastar Pharmaceuticals held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amphastar Pharmaceuticals by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $31k 700 43.91

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Amphastar Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
TD Asset Management
Federated Investors
Neuberger Berman Group
State Street Corporation
Hanna Zanoni
Epoch Investment Partners
Dimensional Fund Advisors
Geode Capital Management
American Century Companies
Morgan Stanley
Northern Trust
T. Rowe Price Associates

View all funds holding Amphastar Pharmaceuticals